Skip to content

Clinical trials

Scleroderma, Diffuse trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Country / region: United Kingdom Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20092
20101
20143
20151
20161
20172
20192
20201
20211
20222
20234
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting6
Recruiting5
Terminated3
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Bristol-Myers Squibb2
CSL Behring2
GlaxoSmithKline2
United Therapeutics2
Amgen1
AstraZeneca1
Corbus Pharmaceuticals Inc.1
Daval International Limited1
Dinesh Khanna, MD, MS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse30
Scleroderma, Systemic13
Lung Diseases, Interstitial7
Autoimmune Diseases3
Connective Tissue Diseases3
Arthritis, Rheumatoid2
Fibrosis2
Immune System Diseases2
Pulmonary Fibrosis2
Raynaud Disease2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.